EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms

Mehraveh Sadeghi Ivraghi, Mohammad Yasin Zamanian iD, Reena Gupta, Harun Achmad, Hashem O Alsaab, Ahmed Hjazi, Rosario Mireya Romero-Parra, Enas R Alwaily, Beneen M Hussien, Elham Hakimizadeh

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14473 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Mehraveh Sadeghi Ivraghi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. Hauptthemen laut MEDLINE: Neuroprotective Agents, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gemfibrozil (Gem) is a drug that has been shown to activate PPAR‐α, a nuclear receptor that plays a key role in regulating lipid metabolism. Gem is used to lower the levels of triglycerides and reduce the risk of coronary heart disease in patients. Experimental studies in vitro and in vivo have shown that Gem can prevent or slow the progression of neurological disorders (NDs), including cerebral ischemia (CI), Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Neuroinflammation is known to play a significant role in these disorders.

Method

The literature review for this study was conducted by searching Scopus, Science Direct, PubMed, and Google Scholar databases.

Result

The results of this study show that Gem has neuroprotective effects through several cellular and molecular mechanisms such as: (1) Gem has the ability to upregulate pro‐survival factors (PGC‐1α and TFAM), promoting the survival and function of mitochondria in the brain, (2) Gem strongly inhibits the activation of NF‐κB, AP‐1, and C/EBPβ in cytokine‐stimulated astroglial cells, which are known to increase the expression of iNOS and the production of NO in response to proinflammatory cytokines, (3) Gem protects dopamine neurons in the MPTP mouse model of PD by increasing the expression of PPARα, which in turn stimulates the production of GDNF in astrocytes, (4) Gem reduces amyloid plaque pathology, reduces the activity of glial cells, and improves memory, (5) Gem increases myelin genes expression (MBP and CNPase) via PPAR‐β, and (6) Gem increases hippocampal BDNF to counteract depression.

Conclusion

According to the study, Gem was investigated for its potential therapeutic effect in NDs. Further research is needed to fully understand the therapeutic potential of Gem in NDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsParkinson DiseaseAnimalsMiceHumansGemfibrozilInflammationPPAR alphaCytokines

Stichwörter der Autor:innen

PPAR-αgemfibrozilneuroinflammationneurological disordersneuroprotective

Substanzen

GemfibrozilNeuroprotective AgentsPPAR alphaCytokines

Autor:innen und Institutionen

  • School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
  • Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Department of Pediatric Dentistry, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.
  • Pharmaceutics and Pharmaceutical Technology, Taif University, Taif, Saudi Arabia.

ORCID-Profile: Mohammad Yasin Zamanian

Zitieren

APA

Ivraghi, M. S., Zamanian, M. Y., Gupta, R., Achmad, H., Alsaab, H. O., Hjazi, A., Romero-Parra, R. M., Alwaily, E. R., Hussien, B. M., & Hakimizadeh, E. (2024). Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14473

Vancouver

Ivraghi MS, Zamanian MY, Gupta R, Achmad H, Alsaab HO, Hjazi A, et al. Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14473

BibTeX
@article{Ivraghi2024,
  author = {Ivraghi, Mehraveh Sadeghi and Zamanian, Mohammad Yasin and Gupta, Reena and Achmad, Harun and Alsaab, Hashem O and Hjazi, Ahmed and Romero-Parra, Rosario Mireya and Alwaily, Enas R and Hussien, Beneen M and Hakimizadeh, Elham},
  title = {Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14473}
}
Kostenlos starten →